Antitumor Potential of Crown Ethers:  Structure−Activity Relationships, Cell Cycle Disturbances, and Cell Death Studies of a Series of Ionophores

Journal of Medicinal Chemistry
2007.0

Abstract

The present paper demonstrates the antiproliferative ability and structure-activity relationships (SAR) of 14 crown and aza-crown ether analogues on five tumor-cell types. The most active compounds were di-tert-butyldicyclohexano-18-crown-6 (3), which exhibited cytotoxicity in the submicromolar range, and di-tert-butyldibenzo-18-crown-6 (5) (IC50 values of approximately 2 microM). Also, 3 and 5 induced marked influence on the cell cycle phase distribution--strong G1 arrest, followed by the induction of apoptosis. A computational SAR modeling effort offers insight into possible mechanisms of crown ether biological activity, presumably involving penetration into cell membranes, and points out structural features of molecules important for this activity. The results reveal that crown ethers possess marked tumor-cell growth inhibitory activity, the extent of which depends on the characteristics of the hydrophilic macrocylic cavity and the surrounding hydrophobic ring. Our work supports the hypothesis that crown ether compounds inhibit tumor-cell growth by disrupting potassium ion homeostasis, which in turn leads to cell cycle perturbations and apoptosis.

Knowledge Graph

Similar Paper

Antitumor Potential of Crown Ethers:  Structure−Activity Relationships, Cell Cycle Disturbances, and Cell Death Studies of a Series of Ionophores
Journal of Medicinal Chemistry 2007.0
Synthesis and biological evaluation of crown ether acyl derivatives
Bioorganic & Medicinal Chemistry Letters 2016.0
Structures and Properties of Naturally Occurring Polyether Antibiotics
BioMed Research International 2013.0
C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: Retention of activity of highly lipophilic analogues against cancer cells
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and SAR of C12–C13-oxazoline derivatives of epothilone A
Bioorganic & Medicinal Chemistry Letters 2009.0
Design and synthesis of new antitumor agents with the 1,7-epoxycyclononane framework. Study of their anticancer action mechanism by a model compound
Bioorganic & Medicinal Chemistry 2018.0
Synthesis and biological evaluation of novel 1-aryl, 5-(phenoxy-substituted)aryl-1,4-pentadien-3-one derivatives
MedChemComm 2011.0
β-Ionone derived chalcones as potent antiproliferative agents
European Journal of Medicinal Chemistry 2013.0
Cytotoxic activity, apoptosis induction and structure–activity relationship of 8-OR-2-aryl-3,4-dihydroisoquinolin-2-ium salts as promising anticancer agents
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis, structure activity relationship and mode of action of 3-substitutedphenyl-1-(2,2,8,8-tetramethyl-3,4,9,10-tetrahydro-2 H ,8 H -pyrano[2,3- f ]chromen-6-yl)-propenones as novel anticancer agents in human leukaemia HL-60 cells
European Journal of Medicinal Chemistry 2013.0